How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma

Autor: Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA

Publikováno v: Patient Preference and Adherence, Vol Volume 12, Pp 2103-2110 (2018)

Amir Khakban,1 Tima Mohammadi,2 Larry D Lynd,1 Don J Mabbott,3,4 Eric Bouffet,5,6 Louise Gastonguay,1 Zafar Zafari,7 David Malkin,5,6 Michael D Taylor,8,9 Carlo A Marra10 1Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical

Externí odkaz: https://doaj.org/article/aa3f5f0b7a6d4f5687161a00cd6beaac

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Integrating priorities at the intersection of cancer and neuroscience.

Autor: Hwang WL; Center for Systems Biology, Center for Cancer Research, and Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Electronic address: whwang1@mgh.harvard.edu., Perrault EN; Center for Systems Biology, Center for Cancer Research, and Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Program in Neuroscience, Department of Neurobiology, Harvard Medical School, Boston, MA, USA., Birbrair A; Department of Dermatology, Carbone Cancer Center, and Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI, USA., Mattson BJ; The Belfer Neurodegeneration Consortium, Therapeutics Discovery Division, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Mabbott DJ; Neurosciences and Mental Health Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada., Cukierman E; Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA; Tumor Microenvironment Working Group, American Association for Cancer Research, Philadelphia, PA, USA., Repasky EA; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Sloan EK; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Zong H; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA., Demir IE; Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; Else Kröner Clinician Scientist Professor, Munich, Germany., Saloman JL; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Borniger JC; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA., Hu J; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dietrich J; Department of Neurology, Center for Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Breunig JJ; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Çifcibaşı K; Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Ahmad Kasm KA; Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Valiente M; Brain Metastasis Group, CNIO, Madrid, Spain., Wintermark M; Department of Neuroradiology, MD Anderson Cancer Center, Houston, TX, USA., Acharya MM; Department of Anatomy and Neurobiology, University of California at Irvine, Irvine, CA, USA., Scheff NN; Department of Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., D'Silva NJ; Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA., Vermeer PD; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, SD, USA., Wong RJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Talbot S; Department of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada., Hervey-Jumper SL; Department of Neurosurgery and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Wang TC; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Ye Y; Translational Research Center, Pain Research Center, Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY, USA., Pan Y; Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bunimovich YL; Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Amit M; Department of Head and Neck Surgery and the Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. Electronic address: mamit@mdanderson.org.

Publikováno v: Cancer cell [Cancer Cell] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.